Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster

This publication has 23 references indexed in Scilit:

• Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6
  Cardiovascular Research, 1986
• Increased cardiac calcium channels in hamster cardiomyopathy
  The American Journal of Cardiology, 1986
• Oxygen-Derived Free Radicals in Postischemic Tissue Injury
  New England Journal of Medicine, 1985
• Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy
  The American Journal of Cardiology, 1985
• Sarcolemmal alterations during the development of genetically determined cardiomyopathy
  Cardiovascular Research, 1984
• The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart
  Basic Research in Cardiology, 1982
• Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
  Circulation, 1982
• Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding
  Cardiovascular Research, 1981
• A Controlled Trial of Verapamil for Prinzmetal's Variant Angina
  New England Journal of Medicine, 1981
• The inhibition of Na+ and K+ stimulated ATPase activity of rabbit and dog heart sarcolemma by lysophosphatidyl choline
  Life Sciences, 1979